Literature DB >> 12486028

Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor.

Bai Lin Tan1, Li Hong, Veerendra Munugalavadla, Reuben Kapur.   

Abstract

Kit receptor tyrosine kinase and erythropoietin receptor (Epo-R) cooperate in regulating blood cell development. Mice that lack the expression of Kit or Epo-R die in utero of severe anemia. Stimulation of Kit by its ligand, stem cell factor activates several distinct early signaling pathways, including phospholipase C gamma, phosphatidylinositol 3-kinase, Src kinase, Grb2, and Grb7. The role of these pathways in Kit-induced growth, proliferation, or cooperation with Epo-R is not known. We demonstrate that inactivation of any one of these early signaling pathways in Kit significantly impairs growth and proliferation. However, inactivation of the Src pathway demonstrated the most profound defect. Combined stimulation with Epo also resulted in impaired cooperation between Src-defective Kit mutant and Epo-R and, to a lesser extent, with Kit mutants defective in the activation of phosphatidylinositol 3-kinase or Grb2. The impaired cooperation between the Src-defective Kit mutant and Epo-R was associated with reduced transphosphorylation of Epo-R and expression of c-Myc. Remarkably, restoration of only the Src pathway in a Kit receptor defective in the activation of all early signaling pathways demonstrated a 50% correction in proliferation in response to Kit stimulation and completely restored the cooperation with Epo-R. These data demonstrate an essential role for Src pathway in regulating growth, proliferation, and cooperation with Epo-R downstream from Kit.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486028     DOI: 10.1074/jbc.M207068200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways.

Authors:  Li Hong; Veerendra Munugalavadla; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver.

Authors:  N Haas; T Riedt; Z Labbaf; K Baßler; D Gergis; H Fröhlich; I Gütgemann; V Janzen; H Schorle
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

3.  Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.

Authors:  Raghuveer Singh Mali; Peilin Ma; Li-Fan Zeng; Holly Martin; Baskar Ramdas; Yantao He; Emily Sims; Sarah Nabinger; Joydeep Ghosh; Namit Sharma; Veerendra Munugalavadla; Anindya Chatterjee; Shuo Li; George Sandusky; Andrew W Craig; Kevin D Bunting; Gen-Sheng Feng; Rebecca J Chan; Zhong-Yin Zhang; Reuben Kapur
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

Review 4.  Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.

Authors:  Brian M Dulmovits; Jimmy Hom; Anupama Narla; Narla Mohandas; Lionel Blanc
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

5.  Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation.

Authors:  Veerendra Munugalavadla; Louis C Dore; Bai Lin Tan; Li Hong; Melanie Vishnu; Mitchell J Weiss; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

Authors:  Valter Agosti; Vinit Karur; Pradeep Sathyanarayana; Peter Besmer; Don M Wojchowski
Journal:  Exp Hematol       Date:  2008-12-18       Impact factor: 3.084

7.  Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease.

Authors:  Peilin Ma; Raghuveer Singh Mali; Holly Martin; Baskar Ramdas; Emily Sims; Reuben Kapur
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

8.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

9.  E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.

Authors:  Jason H Rogers; Kristin S Owens; Jeffrey Kurkewich; Nathan Klopfenstein; Sangeeta R Iyer; M Celeste Simon; Richard Dahl
Journal:  Biomed Res Int       Date:  2016-01-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.